- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 18th, 2007
Osmetech PLC said it has granted a non-exclusive research license to US-based Minerva Biotechnologies Corp for use of its self-assembling monolayer technology in tandem with Minerva's proprietary nanoparticle technology.
Financial terms of the deal were not disclosed.
The molecular diagnostics company said Minerva plans to use the technology for signal enhancement, drug design, drug screening, and functional proteomics.
|Related News Press|
Graphenea celebrates fifth anniversary April 27th, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Heat-Converting Material Patents Licensed April 8th, 2015
From tobacco to cyberwood March 31st, 2015